A Look at the Florida Cannabis Market

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.

Friends,

It has been a little over a year since we discussed how Florida may legalize for adult-use. In that review of the market there, we pointed to the strong but slowing patient growth. The state is still seeing growth in the number of patients, but it is the lowest it has ever been. Florida releases data each week on its program, and this week’s report indicated that there are currently 855,267 qualified patients in the program, up 11.6% from a year ago:

When we reviewed the market in September last year, growth was a record low 22.0%. We pointed out that MMJ products were growing at that rate roughly, but flower units were growing much slower. In the week ending 11/02, MMJ product unit volume grew 17% from a year ago. Flower volume expanded 32%. Florida releases only units and not total revenue, but we believe, based on BDSA data, that revenue in Florida is growing much more slowly. In September, total revenue expanded just 7.5% according to their estimate based on point-of-sale data.

There are 603 dispensaries, and Trulieve continues to lead with 131 (21.7%). The top 5 operators, which include Verano, Ayr Wellness, Curaleaf and Surterra, have 61.4% of the dispensaries in the state. A year ago, there were 489 dispensaries open, so there has been growth of 23.3%, which is double the patient growth! The top 5 then, which are the same companies, had 67.7% of the dispensaries, so there has been more growth among the smaller companies.

Florida is a big state with a large cannabis market that is dominated by publicly-traded MSOs. The growth in patients is slowing but still high, but the revenue is growing slower than the patient growth. We think that the competitive pressures are strong. The state still may legalize, and this would help, but the medical market is very large at almost 4% of Florida’s total population.

Like this newsletter? Sign up, and you will receive a free copy by email each Sunday morning. Each week, we share the top stories and write an original perspective as well.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:

Exclusives

MSOs Lead Cannabis Stocks Lower in October

The Global Cannabis Stock Index Plunges in October

Financial Reports

Cannabis REIT IIPR Beats Analyst Estimates for Q3

Hawthorne Gardening Q4 Revenue Slips 3% Sequentially

To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer the Canadian Cannabis LP Index, the American Cannabis Operator Index and the Ancillary Cannabis Index.

View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.

Sincerely,

Alan & Joel

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email